VCEL
Vericel Corporation$37.55-1.01 (-2.62%)Prev Close$38.57·MCap$1.91B·P/E90.09·Vol229.1K·Yield—
▲
Buys (12M)
0
$0.00
▼
Sells (12M)
22
$4.41M
◆
Net Activity
Net Seller
$4.41M
●
Active Insiders
9
last 12 mo
Over the past 12 months, insider activity at Vericel Corporation (VCEL) has been exclusively selling, with 0 insider purchases totaling $0.00 and 22 insider sales totaling $4.41M. The most recent insider transaction was by Hopper Jonathan Mark (officer: Chief Medical Officer), who sold $153.1K worth of shares on Jun 4, 2026. Vericel Corporation operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $1.91B.
VCEL Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Jun 4, 2026 | Hopper Jonathan Mark | officer: Chief Medical Officer | Sell | 4,375 | $35.00 | $153.1K | 75,753 |
| May 15, 2026 | MCLAUGHLIN KEVIN F | director | Sell | 3,500 | $32.82 | $114.9K | 18,300 |
| May 13, 2026 | Wotton Paul K | director | Sell | 10,000 | $32.74 | $327.4K | 26,302-28% |
| May 8, 2026 | SIEGAL JONATHAN | officer: Principal Accounting Officer | Sell | 4,855 | $38.73 | $188.0K | 2,540-66% |
| May 8, 2026 | Mara Joseph Anthony Jr | officer: Chief Financial Officer | Sell | 5,000 | $40.50 | $202.5K | 21,009 |
| Apr 6, 2026 | Hopper Jonathan Mark | officer: Chief Medical Officer | Sell | 3,472 | $35.00 | $121.5K | 75,556 |
| Mar 25, 2026 | Hagen Heidi | director | Sell | 15,000 | $32.41 | $486.1K | 31,850-32% |
| Feb 18, 2026 | Colangelo Dominick | President and CEO | Sell | 5,657 | $37.41 | $211.6K | 0 |
| Feb 18, 2026 | Flynn Sean C. | Chief Legal Officer | Sell | 2,520 | $37.06 | $93.4K | 0 |
| Feb 18, 2026 | Halpin Michael | Chief Operating Officer | Sell | 4,298 | $37.07 | $159.3K | 0 |
| Feb 18, 2026 | Hopper Jonathan Mark | Chief Medical Officer | Sell | 982 | $37.41 | $36.7K | 0 |
| Feb 18, 2026 | Mara Joseph Anthony Jr | Chief Financial Officer | Sell | 2,314 | $37.03 | $85.7K | 0 |
| Feb 18, 2026 | SIEGAL JONATHAN | Principal Accounting Officer | Sell | 1,305 | $36.90 | $48.2K | 0 |
| Feb 13, 2026 | MCLAUGHLIN KEVIN F | director | Sell | 7,000 | $34.66 | $242.6K | 15,100-32% |
| Jan 9, 2026 | Halpin Michael | officer: Chief Operating Officer | Sell | 10,000 | $40.48 | $404.8K | 16,080-38% |
| Dec 4, 2025 | Hopper Jonathan Mark | Chief Medical Officer | Sell | 1,652 | $39.14 | $64.7K | 66,562 |
| Dec 4, 2025 | Wotton Paul K | Sell | 5,000 | $37.90 | $189.5K | 28,102 | |
| Nov 13, 2025 | Halpin Michael | Chief Operating Officer | Sell | 2,642 | $40.41 | $106.8K | 15,932 |
| Nov 12, 2025 | MCLAUGHLIN KEVIN F | Sell | 7,000 | $38.59 | $270.1K | 15,100-32% | |
| Nov 10, 2025 | Halpin Michael | Chief Operating Officer | Sell | 7,358 | $40.47 | $297.8K | 15,932-32% |
| Sep 3, 2025 | Hopper Jonathan Mark | Chief Medical Officer | Sell | 10,000 | $35.77 | $357.7K | 66,363 |
| Aug 8, 2025 | MCLAUGHLIN KEVIN F | Sell | 7,000 | $35.92 | $251.4K | 15,100-32% | |
| Jun 4, 2025 | Hopper Jonathan Mark | Chief Medical Officer | Sell | 10,000 | $40.09 | $400.9K | 66,237 |
| May 16, 2025 | Colangelo Dominick | President and CEO | Sell | 28,125 | $41.89 | $1.18M | 260,354 |
| May 9, 2025 | MCLAUGHLIN KEVIN F | Sell | 7,000 | $39.98 | $279.9K | 15,100-32% | |
| Apr 11, 2025 | Colangelo Dominick | President and CEO | Sell | 49,700 | $41.50 | $2.06M | 260,354 |
| Mar 14, 2025 | Colangelo Dominick | President and CEO | Sell | 53,183 | $46.04 | $2.45M | 259,997 |
| Mar 5, 2025 | Hagen Heidi | Sell | 9,000 | $49.53 | $445.8K | 28,650 | |
| Mar 5, 2025 | Halpin Michael | Chief Operating Officer | Sell | 10,000 | $49.52 | $495.2K | 15,539-39% |
| Mar 5, 2025 | Hopper Jonathan Mark | Chief Medical Officer | Sell | 10,000 | $49.53 | $495.3K | 66,101 |
| Mar 5, 2025 | Mara Joseph Anthony Jr | Chief Financial Officer | Sell | 9,000 | $49.53 | $445.8K | 13,967-39% |
| Feb 26, 2025 | Flynn Sean C. | Chief Legal Officer | Sell | 1,669 | $52.07 | $86.9K | 756-69% |
| Feb 26, 2025 | SIEGAL JONATHAN | Principal Accounting Officer | Sell | 1,137 | $52.07 | $59.2K | 1,206-49% |
| Feb 24, 2025 | Flynn Sean C. | Chief Legal Officer | Sell | 3,835 | $57.32 | $219.8K | 756-84% |
| Feb 20, 2025 | SIEGAL JONATHAN | Principal Accounting Officer | Sell | 1,710 | $56.72 | $97.0K | 1,206-59% |
| Feb 14, 2025 | MCLAUGHLIN KEVIN F | Sell | 7,000 | $55.46 | $388.3K | 11,900-37% | |
| Feb 7, 2025 | SIEGAL JONATHAN | Principal Accounting Officer | Sell | 1,092 | $61.99 | $67.7K | 1,206-48% |
| Feb 7, 2025 | ZERBE ROBERT L MD | Sell | 2,500 | $62.50 | $156.3K | 26,595 | |
| Jan 30, 2025 | SIEGAL JONATHAN | Principal Accounting Officer | Sell | 3,908 | $61.99 | $242.3K | 1,206-76% |
| Dec 5, 2024 | Wotton Paul K | Sell | 2,600 | $58.72 | $152.7K | 27,402 | |
| Dec 3, 2024 | Hopper Jonathan Mark | Chief Medical Officer | Sell | 10,000 | $58.72 | $587.2K | 58,371 |
| Nov 25, 2024 | ZERBE ROBERT L MD | Sell | 2,500 | $60.00 | $150.0K | 26,595 | |
| Nov 15, 2024 | Colangelo Dominick | President and CEO | Sell | 35,000 | $54.75 | $1.92M | 220,937 |
| Nov 15, 2024 | MCLAUGHLIN KEVIN F | Sell | 7,000 | $55.54 | $388.8K | 11,900-37% | |
| Nov 13, 2024 | ZERBE ROBERT L MD | Sell | 5,000 | $56.25 | $281.3K | 26,595 | |
| Oct 18, 2024 | Colangelo Dominick | President and CEO | Sell | 35,000 | $40.86 | $1.43M | 220,937 |
| Oct 18, 2024 | GILMAN STEVEN C | Sell | 5,833 | $41.36 | $241.3K | 11,000-35% | |
| Oct 4, 2024 | GILMAN STEVEN C | Sell | 5,833 | $40.35 | $235.4K | 11,000-35% | |
| Oct 2, 2024 | SIEGAL JONATHAN | Principal Accounting Officer | Sell | 568 | $41.90 | $23.8K | 1,124-34% |
| Sep 20, 2024 | GILMAN STEVEN C | Sell | 5,834 | $45.54 | $265.7K | 11,000-35% |
Showing 1–50 of 106
1 / 3
VCEL Insider Buying Activity
The following table shows recent insider purchases of Vericel Corporation (VCEL) stock reported via SEC Form 4 filings.
No insider buying activity found for VCEL in the last 12 months.
VCEL Insider Selling Activity
The following table shows recent insider sales of Vericel Corporation (VCEL) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Jun 4, 2026 | Hopper Jonathan Mark | officer: Chief Medical Officer | Sell | 4,375 | $35.00 | $153.1K | 75,753 |
| May 15, 2026 | MCLAUGHLIN KEVIN F | director | Sell | 3,500 | $32.82 | $114.9K | 18,300 |
| May 13, 2026 | Wotton Paul K | director | Sell | 10,000 | $32.74 | $327.4K | 26,302-28% |
| May 8, 2026 | SIEGAL JONATHAN | officer: Principal Accounting Officer | Sell | 4,855 | $38.73 | $188.0K | 2,540-66% |
| May 8, 2026 | Mara Joseph Anthony Jr | officer: Chief Financial Officer | Sell | 5,000 | $40.50 | $202.5K | 21,009 |
| Apr 6, 2026 | Hopper Jonathan Mark | officer: Chief Medical Officer | Sell | 3,472 | $35.00 | $121.5K | 75,556 |
| Mar 25, 2026 | Hagen Heidi | director | Sell | 15,000 | $32.41 | $486.1K | 31,850-32% |
| Feb 18, 2026 | Colangelo Dominick | President and CEO | Sell | 5,657 | $37.41 | $211.6K | 0 |
| Feb 18, 2026 | Flynn Sean C. | Chief Legal Officer | Sell | 2,520 | $37.06 | $93.4K | 0 |
| Feb 18, 2026 | Halpin Michael | Chief Operating Officer | Sell | 4,298 | $37.07 | $159.3K | 0 |
| Feb 18, 2026 | Hopper Jonathan Mark | Chief Medical Officer | Sell | 982 | $37.41 | $36.7K | 0 |
| Feb 18, 2026 | Mara Joseph Anthony Jr | Chief Financial Officer | Sell | 2,314 | $37.03 | $85.7K | 0 |
| Feb 18, 2026 | SIEGAL JONATHAN | Principal Accounting Officer | Sell | 1,305 | $36.90 | $48.2K | 0 |
| Feb 13, 2026 | MCLAUGHLIN KEVIN F | director | Sell | 7,000 | $34.66 | $242.6K | 15,100-32% |
| Jan 9, 2026 | Halpin Michael | officer: Chief Operating Officer | Sell | 10,000 | $40.48 | $404.8K | 16,080-38% |
| Dec 4, 2025 | Hopper Jonathan Mark | Chief Medical Officer | Sell | 1,652 | $39.14 | $64.7K | 66,562 |
| Dec 4, 2025 | Wotton Paul K | Sell | 5,000 | $37.90 | $189.5K | 28,102 | |
| Nov 13, 2025 | Halpin Michael | Chief Operating Officer | Sell | 2,642 | $40.41 | $106.8K | 15,932 |
| Nov 12, 2025 | MCLAUGHLIN KEVIN F | Sell | 7,000 | $38.59 | $270.1K | 15,100-32% | |
| Nov 10, 2025 | Halpin Michael | Chief Operating Officer | Sell | 7,358 | $40.47 | $297.8K | 15,932-32% |
| Sep 3, 2025 | Hopper Jonathan Mark | Chief Medical Officer | Sell | 10,000 | $35.77 | $357.7K | 66,363 |
| Aug 8, 2025 | MCLAUGHLIN KEVIN F | Sell | 7,000 | $35.92 | $251.4K | 15,100-32% | |
| Jun 4, 2025 | Hopper Jonathan Mark | Chief Medical Officer | Sell | 10,000 | $40.09 | $400.9K | 66,237 |
| May 16, 2025 | Colangelo Dominick | President and CEO | Sell | 28,125 | $41.89 | $1.18M | 260,354 |
| May 9, 2025 | MCLAUGHLIN KEVIN F | Sell | 7,000 | $39.98 | $279.9K | 15,100-32% | |
| Apr 11, 2025 | Colangelo Dominick | President and CEO | Sell | 49,700 | $41.50 | $2.06M | 260,354 |
| Mar 14, 2025 | Colangelo Dominick | President and CEO | Sell | 53,183 | $46.04 | $2.45M | 259,997 |
| Mar 5, 2025 | Hagen Heidi | Sell | 9,000 | $49.53 | $445.8K | 28,650 | |
| Mar 5, 2025 | Halpin Michael | Chief Operating Officer | Sell | 10,000 | $49.52 | $495.2K | 15,539-39% |
| Mar 5, 2025 | Hopper Jonathan Mark | Chief Medical Officer | Sell | 10,000 | $49.53 | $495.3K | 66,101 |
| Mar 5, 2025 | Mara Joseph Anthony Jr | Chief Financial Officer | Sell | 9,000 | $49.53 | $445.8K | 13,967-39% |
| Feb 26, 2025 | Flynn Sean C. | Chief Legal Officer | Sell | 1,669 | $52.07 | $86.9K | 756-69% |
| Feb 26, 2025 | SIEGAL JONATHAN | Principal Accounting Officer | Sell | 1,137 | $52.07 | $59.2K | 1,206-49% |
| Feb 24, 2025 | Flynn Sean C. | Chief Legal Officer | Sell | 3,835 | $57.32 | $219.8K | 756-84% |
| Feb 20, 2025 | SIEGAL JONATHAN | Principal Accounting Officer | Sell | 1,710 | $56.72 | $97.0K | 1,206-59% |
| Feb 14, 2025 | MCLAUGHLIN KEVIN F | Sell | 7,000 | $55.46 | $388.3K | 11,900-37% | |
| Feb 7, 2025 | SIEGAL JONATHAN | Principal Accounting Officer | Sell | 1,092 | $61.99 | $67.7K | 1,206-48% |
| Feb 7, 2025 | ZERBE ROBERT L MD | Sell | 2,500 | $62.50 | $156.3K | 26,595 | |
| Jan 30, 2025 | SIEGAL JONATHAN | Principal Accounting Officer | Sell | 3,908 | $61.99 | $242.3K | 1,206-76% |
| Dec 5, 2024 | Wotton Paul K | Sell | 2,600 | $58.72 | $152.7K | 27,402 | |
| Dec 3, 2024 | Hopper Jonathan Mark | Chief Medical Officer | Sell | 10,000 | $58.72 | $587.2K | 58,371 |
| Nov 25, 2024 | ZERBE ROBERT L MD | Sell | 2,500 | $60.00 | $150.0K | 26,595 | |
| Nov 15, 2024 | Colangelo Dominick | President and CEO | Sell | 35,000 | $54.75 | $1.92M | 220,937 |
| Nov 15, 2024 | MCLAUGHLIN KEVIN F | Sell | 7,000 | $55.54 | $388.8K | 11,900-37% | |
| Nov 13, 2024 | ZERBE ROBERT L MD | Sell | 5,000 | $56.25 | $281.3K | 26,595 | |
| Oct 18, 2024 | Colangelo Dominick | President and CEO | Sell | 35,000 | $40.86 | $1.43M | 220,937 |
| Oct 18, 2024 | GILMAN STEVEN C | Sell | 5,833 | $41.36 | $241.3K | 11,000-35% | |
| Oct 4, 2024 | GILMAN STEVEN C | Sell | 5,833 | $40.35 | $235.4K | 11,000-35% | |
| Oct 2, 2024 | SIEGAL JONATHAN | Principal Accounting Officer | Sell | 568 | $41.90 | $23.8K | 1,124-34% |
| Sep 20, 2024 | GILMAN STEVEN C | Sell | 5,834 | $45.54 | $265.7K | 11,000-35% |
VCEL Insiders
Similar Stocks to VCEL
VRTX
Vertex Pharmaceuticals Incorporated
$445.21+0.04%
$113.41B
REGN
Regeneron Pharmaceuticals, Inc.
$614.20+0.45%
$65.47B
ALNY
Alnylam Pharmaceuticals, Inc.
$283.35-2.09%
$40.46B
RVMD
Revolution Medicines, Inc.
$153.65+2.96%
$31.73B
UTHR
United Therapeutics Corporation
$542.43-0.54%
$23.12B
INSM
Insmed Incorporated
$98.28+1.64%
$20.41B
INCY
Incyte Corporation
$108.85+0.95%
$20.11B
MRNA
Moderna, Inc.
$50.18+1.06%
$18.89B